AGIOS PHARMACEUTICALS, INC. Accumulated Other Comprehensive Income
AGIOS PHARMACEUTICALS, INC. (AGIO) had Accumulated Other Comprehensive Income of $25.00 thousand as of 2013-09-30, per its 10-Q filed 2013-11-07.
Discontinued › Balance Sheet › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2013-11-07
- 2013-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $25.00K.
- 2013-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$5.00K.
- 2012-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$2.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2013-09-30 | $25.00K 10-Q · filed 2013-11-07 |
| 2013-06-30 | -$5.00K 10-Q · filed 2013-09-05 |
| 2012-12-31 | -$2.00K 10-Q · filed 2013-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |